[ABCL] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 492.39%
YoY- 224.53%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 10,056 12,192 21,545 101,383 45,917 316,581 139,331 -82.74%
PBT -38,004 -48,148 -31,412 46,587 -6,886 230,809 84,710 -
Tax -7,476 -8,038 -1,519 19,963 -101 62,236 24,762 -
NP -30,528 -40,110 -29,893 26,624 -6,785 168,573 59,948 -
Tax Rate - - - -42.85% - -26.96% -29.23% -
Total Cost 40,584 52,302 51,438 74,759 52,702 148,008 79,383 -36.14%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -303.58 -328.99 -138.75 26.26 -14.78 53.25 43.03 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.11 -0.14 -0.10 0.08 -0.02 0.54 0.21 -
EPS Diluted -0.11 -0.14 -0.10 0.08 -0.02 0.54 0.21 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.